Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation

Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation

<p>Abstract</p> <p>Background</p> <p>As a member of the TNF superfamily, TRAIL could induce human tumor cell apoptosis through its cognate death receptors DR4 or DR5, which can induce formation of the death inducing signaling complex (DISC) and activation of the membran...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Qiao Chunxia, Hu Meiyun, Guo Leiming, Lv Ming, Lin Zhou, Geng Jing, Lang Xiaoling, Li Xinying, Li Yan, Ma Yuanfang, Feng Jiannan, Shen Beifen
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: BMC 2012-07-01
Ráidu:BMC Immunology
Fáttát:
TRAIL
Death receptor 5
Monoclonal antibody
Apoptosis
Breast cancer
Liŋkkat:http://www.biomedcentral.com/1471-2172/13/40

Interneahtta

http://www.biomedcentral.com/1471-2172/13/40

Geahča maid